|  |  | t-test |
---|---|---|---|
U Na (ÎĽmol min -1 ) | |||
HS | Patients | 203 (179; 227)§ | P = 0.215 |
 | Controls | 226 (195; 257)§ |  |
LS | Patients | 42 (31; 53) | P = 0.494 |
 | Controls | 47 (35; 59) |  |
u-EnaC β-CR (pg μmol -1 ) | |||
HS | Patients | 14.33 (12.30; 16.37) | P = 0.980 |
 | Controls | 14.37 (12.34; 16.40) |  |
LS | Patients | 12.54 (11.35; 13.74) | P = 0.084 |
 | Controls | 14.19 (13.00; 15.38) |  |
V (ml min -1 ) | |||
HS | Patients | 2702 (2331; 3074) | P = 0.628 |
 | Controls | 2828 (2442; 3213) |  |
LS | Patients | 2991 (2721; 3260) | P = 0.207 |
 | Controls | 2715 (2353; 3078) |  |
u-AQP2 CR (ng mmol -1 ) | |||
HS | Patients | 143 (117; 168)§ | P = 0.781 |
 | Controls | 147 (129; 165)§ |  |
LS | Patients | 101 (89; 114) | P = 0.192 |
 | Controls | 112 (101; 122) |  |
u-osm (mOsm kg -1 ) | |||
HS | Patients | 405 (363; 447)§ | P = 0.409 |
 | Controls | 436 (372; 499)§ |  |
LS | Patients | 221 (204; 238) | P = 0.026 |
 | Controls | 306 (231; 381) |  |